Author:
Andela Valentine B.,Gingold Brett I.,Souza Mary D.,O'Keefe Regis J.,Puzas Edward J.,Schwarz Edward M.,Rosier Randy N.
Reference23 articles.
1. A.S. Baldwin, Control of oncogenesis and cancer therapy resistance by the transcription factor NF-κB, J. Clin. Invest. 107(3) (2001) 241–246.
2. K.G. Waddick, F.M. Uckun, Innovative treatment programs against cancer: II. Nuclear factor-κB (NFκB) as a molecular target, Biochem. Pharmacol. 57(1) (1999) 9–17.
3. M.A. Sovak, R.E. Bellas, D.W. Kim, G.J. Zanieski, A.E. Rogers, A.M. Traish, G.E. Sonenshein, Aberrant nuclear factor-κB/Rel expression and the pathogenesis of breast cancer, J. Clin. Invest. 100(12) (1997) 2952–2960.
4. B. Rayet, C. Gelinas, Aberrant rel/nfkb genes and activity in human cancer, Oncogene 18(49) (1999) 6938–6947.
5. G. Dong, Z. Chen, T. Kato, C. Van Waes, The host environment promotes the constitutive activation of nuclear factor-κB and proinflammatory cytokine expression during metastatic tumor progression of murine squamous cell carcinoma, Cancer Res. 59(14) (1999) 3495–3504.
Cited by
8 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献